This Looks Like the Perfect Stock for Warren Buffett and Greg Abel to Buy Right Now

McCormick plans to acquire Unilever’s food business in a deal that would roughly double its size, but the stock reaction has been choppy—shares initially fell about 15% as deal scope was digested. The article frames the opportunity as financing support (McCormick needs roughly $16B cash) and a higher-yield setup (about 3.7% yield) versus a ~9x P/E, contrasting the failed Kraft Heinz cost-cutting merger that didn’t sustain innovation.

Analysis

The market is likely over-anchoring on the Kraft Heinz precedent, but the more relevant variable is asset quality and financing structure. A premium consumer-brand roll-up can work if the buyer is paying for distribution/price power rather than just stripping cost; the real risk for MKC is not the thesis, it is balance-sheet drag if the acquisition is financed at a leverage point that forces slower buybacks and constrains pricing flexibility for 12-24 months.

Second-order, the seller may be the cleaner winner than the buyer: UL can exit lower-growth food exposure and redeploy proceeds into higher-ROIC categories, which can support margin mix and capital returns. KHC remains the reputational loser because any failed takeover discussion keeps the market focused on its inability to generate organic growth, and that can sustain multiple compression versus better-run staples. If Berkshire is ever involved as a preferred or structured capital provider, BRK.B gets a low-volatility yield instrument with equity optionality, but only if the transaction is sized conservatively.

The contrarian miss is that MKC’s stock reaction may already discount the obvious integration risk while underpricing the upside if management uses the acquired brands to widen shelf footprint and cross-sell into global channels. Still, this is a months-to-years story, not a days trade: the first catalyst is financing terms and leverage, the second is post-close guidance on synergies and deleveraging, and the thesis breaks if debt/EBITDA rises above a level that forces a dividend reset or slower repurchase cadence. The right way to express it is relative quality, not blind M&A enthusiasm.

Key Decisions for Investors

• Hold off on chasing MKC until financing is disclosed; if net leverage stays manageable and the stock trades back to ~9x forward earnings, initiate a starter long for 6-12 months with a thesis on post-close rerating if deleveraging is visible.
• Watch UL as a relative winner: consider a long UL / short KHC pair over the next 1-3 months, betting that portfolio simplification and capital redeployment support UL while KHC remains a low-growth, low-credibility compounder.
• If Berkshire is formally involved in the financing, buy BRK.B only on a structured-capital announcement; treat it as a defensive income trade rather than an equity-growth catalyst, with downside limited unless the deal becomes rescue-like.
• For MKC holders, use any pre-close volatility to sell upside calls against stock only if implied vol spikes; the risk/reward is skewed toward consolidation, not a fast upside breakout, until synergy evidence appears.